Prestige Consumer Healthcare PBH Incentive stock program, shares reserved for future grants (in shares)

Incentive stock program, shares reserved for future grants (in shares) at other companies

Cardinal HealthCAH

——

AbbottABT

——

Teladoc HealthTDOC

——

Other financials

Income statement

See full

Revenue$281.6M-5.0%

Gross profit$146.3M-13.9%

Operating income$75.5M-14.6%

Net income$53.9M+7.6%

EPS (diluted)$1.13+11.9%

Balance sheet

See full

Cash & equivalents$63.9M-34.8%

Total debt$1.0B-0.2%

Total equity$1.9B+2.9%

Total assets$3.5B+2.7%

Cash flow

See full

Operating cash flow$42.8M-30.7%

CapEx$5.2M+49.8%

Free cash flow$37.6M-35.5%

Valuation

See full

Market cap$2.24B-34.1%

Profitability

See full

Gross margin54.7%-1.1pp

Operating margin28.4%-1.2pp

Net margin17.5%-1.4pp

FCF margin22.6%+1.3pp

Returns & leverage

See full

Return on equity10.2%-2.1pp

Debt / equity0.6×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's incentive stock program, shares reserved for future grants (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prestige Consumer Healthcare's incentive stock program, shares reserved for future grants (in shares)?: Prestige Consumer Healthcare (PBH) reported incentive stock program, shares reserved for future grants (in shares) of $1.4M in Q4 2025.